PMCB — Pharmacyte Biotech Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapNeutral

Annual balance sheet for Pharmacyte Biotech, fiscal year end - April 30th, USD millions except per share, conversion factor applied.

	2022 April 30th	2023 April 30th	2024 April 30th	2025 April 30th	2026 April 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	85.4	68	50.2	18.5	37.1
Net Total Receivables	—	—	—	3.7	0.241
Prepaid Expenses
Total Current Assets	85.5	68.1	50.4	22.4	37.4
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	90.6	73.3	59.9	55.2	46.8
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	0.704	0.587	7.42	2.91	0.826
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	0.704	0.587	20.4	3.28	11.8
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	89.9	72.7	39.5	51.9	35
Total Liabilities & Shareholders' Equity	90.6	73.3	59.9	55.2	46.8
Total Common Shares Outstanding
Total Preferred Shares Outstanding